These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33658066)
1. The important herbal pair for the treatment of COVID-19 and its possible mechanisms. Xia S; Zhong Z; Gao B; Vong CT; Lin X; Cai J; Gao H; Chan G; Li C Chin Med; 2021 Mar; 16(1):25. PubMed ID: 33658066 [TBL] [Abstract][Full Text] [Related]
2. Herbal combinations against COVID-19: A network pharmacology, molecular docking and dynamics study. Song JB; Zhao LQ; Wen HP; Li YP J Integr Med; 2023 Nov; 21(6):593-604. PubMed ID: 37805293 [TBL] [Abstract][Full Text] [Related]
3. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification. Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419 [TBL] [Abstract][Full Text] [Related]
4. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents. Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269 [TBL] [Abstract][Full Text] [Related]
5. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic. Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819 [TBL] [Abstract][Full Text] [Related]
6. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking. Gao LQ; Xu J; Chen SD Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717 [TBL] [Abstract][Full Text] [Related]
7. Network Pharmacology Analysis of Traditional Chinese Medicine for Treating Psoriasis: Identifying Core Components, Mechanisms, and Dosing Patterns. Yang S; Hu X; Wang Z Altern Ther Health Med; 2024 Jul; ():. PubMed ID: 39038330 [TBL] [Abstract][Full Text] [Related]
8. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448 [TBL] [Abstract][Full Text] [Related]
9. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. Ren X; Shao XX; Li XX; Jia XH; Song T; Zhou WY; Wang P; Li Y; Wang XL; Cui QH; Qiu PJ; Zhao YG; Li XB; Zhang FC; Li ZY; Zhong Y; Wang ZG; Fu XJ J Ethnopharmacol; 2020 Aug; 258():112932. PubMed ID: 32376368 [TBL] [Abstract][Full Text] [Related]
10. Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology. Zheng WJ; Yan Q; Ni YS; Zhan SF; Yang LL; Zhuang HF; Liu XH; Jiang Y BioData Min; 2020; 13():17. PubMed ID: 33082858 [TBL] [Abstract][Full Text] [Related]
11. Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology. Ye XW; Deng YL; Zhang X; Liu MM; Liu Y; Xie YT; Wan Q; Huang M; Zhang T; Xi JH; Zhang JL Drug Dev Ind Pharm; 2021 Aug; 47(8):1279-1289. PubMed ID: 34605344 [TBL] [Abstract][Full Text] [Related]
12. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019. Xing Y; Hua YR; Shang J; Ge WH; Liao J Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725 [TBL] [Abstract][Full Text] [Related]
13. Investigation into molecular mechanisms and high-frequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining. Yu MX; Song X; Ma XQ; Hao CX; Huang JJ; Yang WH Ann Palliat Med; 2021 Apr; 10(4):3960-3975. PubMed ID: 33832291 [TBL] [Abstract][Full Text] [Related]
14. [Medication law and mechanism of traditional Chinese medicine in prevention and treatment of epidemic diseases: based on traditional Chinese medicine theory of cold pestilence]. Li ZY; Hao EW; Cao R; Lin S; Chen SY; Huang XT; Xu WR; Hou XT; Deng JG Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4765-4777. PubMed ID: 36164884 [TBL] [Abstract][Full Text] [Related]
15. Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection. Li H; Sun M; Lei F; Liu J; Chen X; Li Y; Wang Y; Lu J; Yu D; Gao Y; Xu J; Chen H; Li M; Yi Z; He X; Chen L Antiviral Res; 2024 Apr; 224():105841. PubMed ID: 38408645 [TBL] [Abstract][Full Text] [Related]
16. Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3. Luo W; Ding R; Guo X; Zhan T; Tang T; Fan R; Wang Y Comput Biol Med; 2022 Jun; 145():105457. PubMed ID: 35366469 [TBL] [Abstract][Full Text] [Related]
17. The mechanism and active compounds of semen Wang Y; Gu W; Kui F; Gao F; Niu Y; Li W; Zhang Y; Guo Z; Du G Food Nutr Res; 2021; 65():. PubMed ID: 34908920 [TBL] [Abstract][Full Text] [Related]
18. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19). Li X; Qiu Q; Li M; Lin H; Cao S; Wang Q; Chen Z; Jiang W; Zhang W; Huang Y; Luo H; Luo L Aging (Albany NY); 2021 Feb; 13(4):4811-4830. PubMed ID: 33581688 [TBL] [Abstract][Full Text] [Related]
19. Identification of phytochemical compounds of Zhang M; Zhang X; Pei J; Guo B; Zhang G; Li M; Huang L Heliyon; 2023 Mar; 9(3):e14029. PubMed ID: 36911881 [TBL] [Abstract][Full Text] [Related]
20. Bioactive Components of Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]